Introduction and first reading Second reading and referral to committee Committee report presented Debate at report stage Debate at third reading Third reading First reading Debate at second reading Debate at second reading Debate at second reading Committee report presented Debate at third reading Royal assent Export of generic medicines to developing countries (Canadian HIV/AIDS Legal Network) UN RIGHTS EXPERT WELCOMES CANADIAN INITIATIVE ON ACCESS TO LOW-COST DRUGS IN DEVELOPING COUNTRIES (United Nations Press Release) Government of Canada Moving Forward with Legislation to Improve Access to Medicines in Developing Countries (Industry Canada) Prime Minister’s statement on amendments to Bill C-9, The Jean Chrétien Pledge To Africa Act (Office of the Prime Minister) Out-licensing: a practical approach for improvement of access to medicines in poor countries Protection racket: drugs companies are tightening their hold on Third World markets Experts clash over liklely impact of cheap AIDS drugs in Africa A war over drugs and patents Drug-induced dilemma Symptomatic relief: drugs, patents and the WTO Intellectual property and the AIDS pandemic Intellectual property and the AIDS pandemic Medicines for the developing world: promoting access and innovation in the post-TRIPS environment Intellectual property - patents and copyright Accès des pays pauvres aux soins et aux médicaments : un espoir enfin?

FTAA [Free Trade Agreement of the Americas] could interfere with proposed Canadian patent legislation allowing generic exports New free trade agreement could make generic drugs less accessible in the Americas Distributive politics and international institutions: the case of drugs The G8 fails global health In Africa, patents kill No turning back on cheap AIDS drugs for poor nations, UN vows The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS Martin government to reintroduce patent changes Hold-up sur le médicament